ESSENTIAL SYSTEMIC HYPERTENSION: GENETICS, CLINICS, EXPERIMENT
نویسندگان
چکیده
منابع مشابه
Genetics of essential hypertension.
Essential hypertension affects 1 billion people worldwide and its genetic basis is well established. For this review we surveyed the literature on the genetics of hypertension during the past 18 months and we now report the highlights. There has been publication of the two largest genome scans for blood pressure and new loci including significant linkage to chromosome 6q have been reported. The...
متن کاملMitochondrial genetics and human systemic hypertension.
Evolution of biological processes is fascinating and more so the evolutionary reduction of mitochondrial genome. A proteobacterium that invaded the nucleus-containing host cell 1.5 billion years ago, as would the endosymbiotic model surmises,1 ended up enslaved and yet became the essence of life of the invaded cell. And, if so, the invader could not have had a genome that was comprised of only ...
متن کاملPhenylketonuria from Genetics to Clinics: An Iranian Prospect
Phenylketonuria (PKU) is the most common autosomal recessive disorder of amino acid metabolism. Thedisease is caused mainly by mutations in the phenylalanine hydroxylase (PAH) gene, encoding phenylalaninehydroxylase (PAH) enzyme. The PAH enzyme deficiency results in the elevation of phenylalanine inthe blood, which may cause severe irreversible mental retardation in the affect...
متن کاملGenetics of essential hypertension: from families to genes.
Family studies demonstrated the contribution of genetic factors to the development of primary hypertension. However, the transition from this phenomenologic-biometric approach to the molecular-genetic one is more difficult. This last approach is mainly based on the Mendel paradigm; that is, the dissection of the poligenic complexity of hypertension is brought about on the assumption that the in...
متن کاملSystemic Hemodynamic Effects of Bethanidine in Essential Hypertension By STEVEN
Although available elsewhere, bethanidine remains under study in the U.S. and its hemodynamic effects are unreported. Therefore, 29 patients with moderately severe essential hypertension received one of four oral dose levels (0.10, 0.25, 0.35, or 0.50 mg/kg) of the postganglionic sympatholytic drug. Blood pressure was reduced only in the 14 patients receiving the highest dose. This was demonstr...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Russian Journal of Cardiology
سال: 2017
ISSN: 1560-4071
DOI: 10.15829/1560-4071-2017-10-133-139